Healthcare provider profile · identity verified

Jaime Chavarria, MD

Internal Medicine · PASADENA, TX · NPI 1457382970

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	945	364
Metformin Hcl	Metformin Hcl	576	221
Gabapentin	Gabapentin	397	151
Lisinopril	Lisinopril	395	151
Amlodipine Besylate	Amlodipine Besylate	371	144
Escitalopram Oxalate	Escitalopram Oxalate	277	93
Omeprazole	Omeprazole	257	113
Levothyroxine Sodium	Levothyroxine Sodium	240	91
Losartan Potassium	Losartan Potassium	221	86
Pioglitazone Hcl	Pioglitazone Hcl	215	83
Tamsulosin Hcl	Tamsulosin Hcl	211	87
Baclofen	Baclofen	191	58
Metoprolol Tartrate	Metoprolol Tartrate	188	73
Glimepiride	Glimepiride	174	67
Oxybutynin Chloride Er	Oxybutynin Chloride	173	57
Fluticasone Propionate	Fluticasone Propionate	169	70
Furosemide	Furosemide	166	56
Albuterol Sulfate Hfa	Albuterol Sulfate	165	70
Tizanidine Hcl	Tizanidine Hcl	159	66
Clopidogrel	Clopidogrel Bisulfate	140	44
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	140	52
Simvastatin	Simvastatin	138	53
Famotidine	Famotidine	136	46
Pantoprazole Sodium	Pantoprazole Sodium	135	57
Carvedilol	Carvedilol	132	52
Alendronate Sodium	Alendronate Sodium	118	44
Ropinirole Hcl	Ropinirole Hcl	118	48
Trulicity	Dulaglutide	107	30
Trazodone Hcl	Trazodone Hcl	106	35
Pravastatin Sodium	Pravastatin Sodium	104	41
Finasteride	Finasteride	100	36
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	98	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	97	29
Sertraline Hcl	Sertraline Hcl	96	32
Glycopyrrolate	Glycopyrrolate	91	46
Bupropion Xl	Bupropion Hcl	89	38
Rosuvastatin Calcium	Rosuvastatin Calcium	89	40
Tramadol Hcl	Tramadol Hcl	87	42
Sildenafil Citrate	Sildenafil Citrate	85	17
Glipizide	Glipizide	84	31
Eliquis	Apixaban	82	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	79	29
Diclofenac Sodium	Diclofenac Sodium	75	26
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	72	23
Chlorthalidone	Chlorthalidone	72	31
Hydrochlorothiazide	Hydrochlorothiazide	72	31
Fenofibrate	Fenofibrate	71	28
Ozempic	Semaglutide	71	16
Metformin Hcl Er	Metformin Hcl	63	26
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	60	58
Metoprolol Succinate	Metoprolol Succinate	56	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	15
Atenolol	Atenolol	52	18
Latanoprost	Latanoprost	52	18
Pregabalin	Pregabalin	49	16
Allopurinol	Allopurinol	48	19
Hydralazine Hcl	Hydralazine Hcl	48	22
Nifedipine Er	Nifedipine	48	21
Duloxetine Hcl	Duloxetine Hcl	46	20
Ezetimibe	Ezetimibe	43	20
Venlafaxine Hcl	Venlafaxine Hcl	43	11
Clonidine Hcl	Clonidine Hcl	39	15
Januvia	Sitagliptin Phosphate	39	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	39	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	38	38
Potassium Chloride	Potassium Chloride	37	16
Lorazepam	Lorazepam	36	17
Acetaminophen-Codeine	Acetaminophen With Codeine	35	18
Cilostazol	Cilostazol	35	13
Citalopram Hbr	Citalopram Hydrobromide	34	16
Doxepin Hcl	Doxepin Hcl	33	suppressed
Enalapril Maleate	Enalapril Maleate	33	15
Mounjaro	Tirzepatide	32	suppressed
Farxiga	Dapagliflozin Propanediol	30	11
Glipizide Er	Glipizide	30	13
Montelukast Sodium	Montelukast Sodium	28	11
Valsartan	Valsartan	28	12
Calcitriol	Calcitriol	27	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	26	suppressed
Novolog Flexpen	Insulin Aspart	26	suppressed
Clonazepam	Clonazepam	24	suppressed
Meloxicam	Meloxicam	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Lovastatin	Lovastatin	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Hydrocortisone	Hydrocortisone	20	12
Warfarin Sodium	Warfarin Sodium	20	suppressed
Nystatin	Nystatin	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Fluocinonide	Fluocinonide	17	13
Jardiance	Empagliflozin	17	suppressed
Nitroglycerin	Nitroglycerin	17	11
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	13
Prednisone	Prednisone	16	11
Spironolactone	Spironolactone	16	suppressed
Temazepam	Temazepam	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Ketoconazole	Ketoconazole	14	11
Lansoprazole	Lansoprazole	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	13
Halobetasol Propionate	Halobetasol Propionate	13	suppressed
Topiramate	Topiramate	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error